Dihydroartemisinin Clinical Trials

2 actively recruiting trials

▲ +1 trial since June 2026

Pipeline

Phase 2: 1Phase 1/2: 1

Top Sponsors

The First Affiliated Hospital with Nanjing Medical University1
Shanghai Zhongshan Hospital1

Indications

MAFLD1
Liver Disease1
Polycystic Ovary Syndrome (PCOS)1
Cancer1

Other2 trials

Dihydroartemisinin for MAFLD

Phase 1/2

Dihydroartemisinin for the Treatment of Polycystic Ovary Syndrome

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.